Suppr超能文献

肝移植术中使用移动透析系统进行术中透析。

Intraoperative dialysis with the use of a mobile dialysis system during liver transplantation.

机构信息

Department of Nephrology, Dialysis and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.

Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Warsaw, Poland.

出版信息

Adv Med Sci. 2022 Sep;67(2):208-215. doi: 10.1016/j.advms.2022.04.004. Epub 2022 May 11.

Abstract

PURPOSE

Over the last few years, transplant centers have started to use various intraoperative renal replacement therapy (ioRRT) modalities during liver transplantation (LT) in patients with pre-existing renal impairment. Here, we present a study on the safety and clinical outcomes of intraoperative hemodialysis (ioHD) performed using a mobile dialysis system during LT.

PATIENTS AND METHODS

We retrospectively analyzed 102 adult patients undergoing LT with ioHD; pre-existing renal failure and/or intraoperative metabolic derangement were ioHD treatment indications.

RESULTS

Our study cohort consisted of three groups: LT with preoperative serum creatinine (sCr) ​< ​2 ​mg/dL (Group 1:n ​= ​22), LT with preoperative sCr ≥2 ​mg/dL (Group 2:n ​= ​73), and simultaneous liver-kidney transplantation (Group 3:n ​= ​7). Among the procedures, 30% were re-transplantations. The mean calculated Model for End-stage Liver Disease score in Group 2 was 39.2, and 67% of patients were hospitalized in the intensive care unit. Patients in Group 1 were less acutely ill but developed severe intraoperative derangements and, therefore, underwent urgent ioHD intraoperatively. However, it was delayed when compared to Group 2. All groups achieved post-reperfusion potassium levels <4 ​mmol/L and a decrease in central venous pressure. No serious procedural complications occurred. Post-reperfusion syndrome occurred in 12.7% of patients. Elevated mortality was likely due to the high illness severity in the cohort.

CONCLUSIONS

Performing ioHD with a mobile dialysis system during LT was safe and effective, while being easier to perform than continuous techniques. Its effect on intra- and postoperative outcomes should be addressed in a study with a control group.

摘要

目的

在过去的几年中,移植中心开始在存在预先存在的肾功能损害的患者中在肝移植 (LT) 期间使用各种术中肾脏替代治疗 (ioRRT) 方式。在这里,我们介绍了在 LT 期间使用移动透析系统进行术中血液透析 (ioHD) 的安全性和临床结果的研究。

患者和方法

我们回顾性分析了 102 例接受 ioHD 的成人 LT 患者;预先存在的肾衰竭和/或术中代谢紊乱是 ioHD 治疗的指征。

结果

我们的研究队列包括三组:术前血清肌酐 (sCr) < 2 mg/dL 的 LT (组 1:n = 22)、术前 sCr ≥2 mg/dL 的 LT (组 2:n = 73) 和同时进行的肝-肾移植 (组 3:n = 7)。在这些手术中,有 30%是再次移植。组 2 的平均计算的终末期肝病模型评分为 39.2,67%的患者住院于重症监护病房。组 1 的患者病情较轻,但术中出现严重的代谢紊乱,因此需要紧急进行术中 ioHD。但是与组 2 相比,时间上有所延迟。所有组均在再灌注后达到血钾水平 <4 mmol/L 和中心静脉压降低。没有发生严重的程序并发症。再灌注后综合征发生在 12.7%的患者中。高死亡率可能是由于该队列中患者的疾病严重程度较高所致。

结论

在 LT 期间使用移动透析系统进行 ioHD 是安全有效的,而且比连续技术更容易进行。在具有对照组的研究中,应该探讨其对术中及术后结果的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验